Equillium, Inc. announced on September 3, 2025, that its Compensation Committee granted inducement awards to two new employees on August 29, 2025. These awards consist of nonstatutory stock options to purchase an aggregate of 150,000 shares of common stock.
The stock options were granted under Equillium’s 2024 Inducement Plan, with an exercise price per share equal to $1.74, which was the company’s closing stock price on August 29. This grant is intended as an inducement material to the new employees' employment.
Each stock option will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date, and the remaining balance vesting monthly over the subsequent 36 months, subject to continued service.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.